Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 W 4th Avenue, Vancouver, Canada

Stocktradesmoon Sep. 23 at 1:21 PM

$ABCL

0 · Reply

JiZzM0pper216 Sep. 23 at 11:53 AM

$ABCL brilliant move, October 1st rio presentation. 1+billion menopausal South American babes looking for a treatment with no side effects. Let's go.

1 · Reply

JiZzM0pper216 Sep. 23 at 9:30 AM

$ABCL is making world news! YahooFinanceUK let's Go!!!

0 · Reply

Stocktradesmoon Sep. 23 at 4:48 AM

$ABCL It’s about to Get VERY EXCITING here!! With this Signal Confirmed ✅ we are 💯 heading to $17’sss-$20’sss by next week. This movement is just Starting Today establishing US to Mid $13’sss taking us NEW 52 WEEK HIGH!! I’m so EXCITED 😆! 🔥 With Major Catalyst in a few days the “2026 IMS MENOPAUSE Convention Conference! The Largest in the World 🌍 🗺️!! 🔥 Also, They will be Releasing the Impressive Phase II RESULTS 12 WEEK (90 DAY DATA 📊)‼️ 🔥 We are also expecting more Great NEWS 🗞️ Premarket today or After-hours tomorrow!! Partnership?? 🔥 Finally, People can’t stop talking about the Carl’s CEO Conference Call. I don’t blame them personally I think it was the BEST 30 Minute Conference from any CEO I have EVER LISTENED too!! It’s a MUST LISTEN 🎧!! 🔥 In Carl’s own words “Patients were CURED” yes he said “CURED”. Patients went from 10 Events a day to “ZERO” in less than 4 weeks. 🤯 🔥 BLACKROCK #1 FINANCIAL INSTITUTION 🏦 in the world went from $15M to now buying 45 Million Shares 😮

1 · Reply

Merlintrader Sep. 23 at 4:43 AM

$ABCL

1 · Reply

Kaykay610 Sep. 23 at 2:00 AM

$ABCL The Canadian government is fully invested nurturing their champion!! The clinical and research section will be done in 2029 around the time abcellera will be ready for the phase 2/3 of their program. This is way bigger than 635 and has been planned out b4 i bought my 16 shares https://youtu.be/xlLTlChs64M?is=JBX_cojGNGsCf7sW St paul was mentioned at (0:52:36) and again at (0:59:43).

0 · Reply

Stocktradesmoon Sep. 22 at 7:56 PM

$ABCL Last Chance to GET IN‼️ GET in NOW you will THANK ME LATER!! Don’t have me tell you “I TOLD you so AGAIN”!! 😆 Mid to High $13.50’ss-$13.70’sss Tomorrow! GREAT Job WAJeff for adding here $12.75’ss!! 🔥 It continues to form a pennant, and the atlas signal remains active. 🔥 the cfi keeps going and keeps adding up ⬆️ Anybody that needs to see it for themselves…HERE it is!! You been told $17’sss-20’sss will be here by the 2026 LARGEST in the WORLD 🌎 🗺️ IMS MENOPAUSE Convention Conference early next week!! 🚨MARK this POST‼️

0 · Reply

Stocktradesmoon Sep. 22 at 7:53 PM

$ABCL $ABVX

1 · Reply

Stocktradesmoon Sep. 22 at 7:52 PM

$ABCL 👀

0 · Reply

Bastox Sep. 22 at 7:52 PM

$ABCL Wait Moonprance. You said 13's. You said big rally? Aren't you getting tired of being wrong all the time?

0 · Reply

AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause

Sep 16, 2026, 4:05 PM EDT - 6 days ago

AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026

Sep 9, 2026, 2:10 PM EDT - 13 days ago

AbCellera Biologics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Sep 2, 2026, 4:05 PM EDT - 20 days ago

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

2026-08-25T16:06:05.000Z - 4 weeks ago

AbCellera rises 17.0%

2026-08-25T14:06:36.000Z - 4 weeks ago

AbCellera rises 10.7%

Aug 13, 2026, 12:05 AM EDT - 5 weeks ago

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

2026-08-11T20:05:47.000Z - 6 weeks ago

AbCellera announces $200M common stock, warrants offering

Aug 11, 2026, 4:01 PM EDT - 6 weeks ago

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

2026-08-11T13:35:37.000Z - 6 weeks ago

AbCellera price target raised to $30 from $12 at Truist

2026-08-10T19:55:32.000Z - 6 weeks ago

AbCellera price target raised to $25 from $13 at JonesResearch

Aug 10, 2026, 8:00 AM EDT - 6 weeks ago

AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 6 weeks ago

AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:23 AM EDT - 6 weeks ago

This Biotech's Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.

Aug 10, 2026, 7:13 AM EDT - 6 weeks ago

AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise

2026-08-10T11:11:27.000Z - 6 weeks ago

AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints

Aug 10, 2026, 7:00 AM EDT - 6 weeks ago

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Aug 7, 2026, 4:30 PM EDT - 6 weeks ago

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

2026-08-06T12:20:50.000Z - 6 weeks ago

AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:12:02.000Z - 6 weeks ago

AbCellera price target raised to $12 from $11 at Cantor Fitzgerald

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 6 weeks ago

AbCellera Reports Q2 2026 Business Results

2026-07-29T11:27:06.000Z - 1 month ago

AbCellera announces collaboration with Vertex Pharmaceuticals

VRTX

Jul 29, 2026, 7:00 AM EDT - 1 month ago

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

2026-07-09T21:29:02.000Z - 2 months ago

3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts

NUVB SERV UBER

Jul 7, 2026, 4:05 PM EDT - 2 months ago

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

2026-07-07T10:35:14.000Z - 2 months ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ

Jul 6, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jun 17, 2026, 7:43 AM EDT - 3 months ago

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

JAZZ

Jun 17, 2026, 7:00 AM EDT - 3 months ago

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

Jun 5, 2026, 9:00 AM EDT - 3 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 4, 2026, 11:40 AM EDT - 3 months ago

AbCellera Biologics Transcript: Jefferies Global Healthcare Conference 2026

May 13, 2026, 8:00 PM EDT - 4 months ago

AbCellera Biologics Transcript: Bank of America Global Healthcare Conference 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Slides: Q1 2026

May 11, 2026, 4:05 PM EDT - 4 months ago

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

May 7, 2026, 4:05 PM EDT - 4 months ago

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

Apr 21, 2026, 1:30 PM EDT - 5 months ago

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Apr 20, 2026, 9:00 AM EDT - 5 months ago

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Apr 1, 2026, 4:05 PM EDT - 5 months ago

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Mar 17, 2026, 4:30 PM EDT - 6 months ago

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 4, 2026, 9:50 AM EST - 6 months ago

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 4:05 PM EST - 7 months ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 7 months ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 8 months ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 6:45 PM EST - 8 months ago

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:00 AM EST - 8 months ago

AbCellera Biologics Slides: Corporate presentation

Jan 12, 2026, 9:00 AM EST - 8 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 9 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 9 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 3, 2025, 8:00 AM EST - 9 months ago

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Sep 29, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 1 year ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 9:00 AM EDT - 1 year ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation

Jul 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 9, 2025, 10:40 AM EDT - 1 year ago

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 1:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 1 year ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 1 year ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results

May 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

Apr 29, 2025, 3:00 PM EDT - 1 year ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 19, 2025, 1:30 PM EDT - 1 year ago

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

Mar 3, 2025, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 3, 2024, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 19, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

Nov 18, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Stocktradesmoon Sep. 23 at 1:21 PM

$ABCL

0 · Reply

JiZzM0pper216 Sep. 23 at 11:53 AM

$ABCL brilliant move, October 1st rio presentation. 1+billion menopausal South American babes looking for a treatment with no side effects. Let's go.

1 · Reply

JiZzM0pper216 Sep. 23 at 9:30 AM

$ABCL is making world news! YahooFinanceUK let's Go!!!

0 · Reply

Stocktradesmoon Sep. 23 at 4:48 AM

1 · Reply

Merlintrader Sep. 23 at 4:43 AM

$ABCL

1 · Reply

Kaykay610 Sep. 23 at 2:00 AM

0 · Reply

Stocktradesmoon Sep. 22 at 7:56 PM

0 · Reply

Stocktradesmoon Sep. 22 at 7:53 PM

$ABCL $ABVX

1 · Reply

Stocktradesmoon Sep. 22 at 7:52 PM

$ABCL 👀

0 · Reply

Bastox Sep. 22 at 7:52 PM

$ABCL Wait Moonprance. You said 13's. You said big rally? Aren't you getting tired of being wrong all the time?

0 · Reply

Ckkung71 Sep. 22 at 7:51 PM

$ABCL Do they really manage to foul any penny traders with this shit?

0 · Reply

Stocktradesmoon Sep. 22 at 7:51 PM

$ABCL Yes. It’s Coming. Get Ready!

0 · Reply

Ckkung71 Sep. 22 at 7:45 PM

$ABCL 😏

0 · Reply

Vippizipi Sep. 22 at 7:34 PM

$ABCL Happy Wife, Happy Life! Thanks to ABCL in 2026

0 · Reply

Bastox Sep. 22 at 7:25 PM

$ABCL Suoper MooniePie back with his wrong calls. I love the "we think a parntership will be announced". Whose "we"? What a joke. Wromng all the time.

0 · Reply

Bastox Sep. 22 at 7:17 PM

$ABCL Moondumb. All day long with wrong calls. Hey Moonage, what about that wrong call for 13’s by the close yesterday? Ooopsies

0 · Reply

Stocktradesmoon Sep. 22 at 7:03 PM

$ABCL It’s about to Get very EXCITING here!! With this Signal Confirmed ✅ we are 💯 heading to $17’sss-$20’sss by next week. This movement is just Starting Today establishing US to Mid $13’sss taking us NEW 52 WEEK HIGH!! I’m so EXCITED 😆! 🔥 With Major Catalyst in a few days the “2026 IMS MENOPAUSE Convention Conference! The Largest in the World 🌍 🗺️!! 🔥 Also, They will be Releasing the Impressive Phase II RESULTS 12 WEEK (90 DAY DATA 📊)‼️ 🔥 We are also expecting more Great NEWS 🗞️ After HOURS today or Premarket tomorrow!! Partnership?? 🔥 Finally, People can’t stop talking about the Carl’s CEO Conference Call. I don’t blame them personally I think it was the BEST 30 Minute Conference from any CEO I have EVER LISTENED too!! It’s a MUST LISTEN 🎧!! 🔥 In Carl’s own words “Patients were CURED” yes he said “CURED”. Patients went from 10 Events a day to “ZERO” in less than 4 weeks. 🤯 🔥 BLACKROCK #1 FINANCIAL INSTITUTION 🏦 in the world went from $15M to now buying 45 Million Shares 😮

0 · Reply

ITF Sep. 22 at 6:48 PM

$ABCL 1.i'm very bullish 2. close today above 12.75 will be massive 3. next resistance lies between 14.18 - 15.04 4. no catalyst that is known ( that i'm aware off soon) 5. once it reaches next resistance a handle to the massive cup will form' 0.618 fib suggests a pull back all the way to 6.84 ( average , pulled from 14.6 resistance) 6. catalyst or just continued accumulation towards 3rd stage results will lead to eruption over 20's 7. i'm thinking of selling 1/3 of my position around 14.5 and will wait for bottom handle to reload 8 thoughts?

5 · Reply

Stocktradesmoon Sep. 22 at 5:58 PM

$ABCL Look 👀 LEVEL II another 300,000 Shares BOUGHT in the last few minutes. Now 👀 at my Chart 📈 $ABCL is going to MOON 🚀. We also expecting news after hours today if not by tomorrow morning!

1 · Reply

Gurufatcat Sep. 22 at 5:50 PM

$ABCL let’s go to 20s

0 · Reply

Stocktradesmoon Sep. 22 at 5:39 PM

$ABCL Last Chance to GET IN‼️ GET in NOW you will THANK ME LATER!! Don’t have me tell you “I TOLD you so AGAIN”!! 😆 Mid to High $13.50’ss-$13.70’sss Today! GREAT Job WAJeff for adding here $12.75’ss!! 🔥 It continues to form a pennant, and the atlas signal remains active. 🔥 the cfi keeps going and keeps adding up ⬆️ Anybody that needs to see it for themselves…HERE it is!! You been told $17’sss-20’sss will be here by the 2026 LARGEST in the WORLD 🌎 🗺️ IMS MENOPAUSE Convention Conference early next week!! 🚨MARK this POST‼️

0 · Reply

WAJeff Sep. 22 at 5:15 PM

$ABCL Followed up 9.43 add on 8/10 and 11.85 add on 8/19 with a smidge more here at 12.67

0 · Reply

Market Cap	3.88B
Revenue (ttm)	75.13M
Net Income (ttm)	-146.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-194.88%
Debt to Equity Ratio	0.00

Volume	4,283,200
Avg Vol	6,905,018
Day's Range	N/A - N/A
Shares Out	306.61M
Stochastic %K	81%
Beta	1.32
Analysts	Strong Sell
Price Target	$17.12